Diagnóstico y seguimiento de 12 casos de peritonitis esclerosante asociada a diálisis peritoneal crónica en Chile: Experience in 12 patients on peritoneal dialysis
| Autor: | Paula Segura, Rubén Torres, Miriam Alvo, María Eugenia Sanhueza, Paula Ebner, Erico Segovia |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Abdominal pain medicine.diagnostic_test business.industry medicine.medical_treatment Peritonitis Peritoneal Fibrosis General Medicine medicine.disease Asymptomatic 030218 nuclear medicine & medical imaging Peritoneal dialysis Surgery 03 medical and health sciences Catheter 0302 clinical medicine Biopsy medicine medicine.symptom business Complication Peritoneal Dialysis |
| Zdroj: | Revista médica de Chile v.145 n.1 2017 SciELO Chile CONICYT Chile instacron:CONICYT |
| ISSN: | 0034-9887 |
| DOI: | 10.4067/s0034-98872017000100006 |
| Popis: | Background: Encapsulating peritoneal sclerosis (EPS) is a complication of peritoneal dialysis (PD) with a low prevalence but high mortality. It is characterized by peritoneal inflammation and fibrosis with subsequent development of intestinal encapsulation. It is associated with a long lapse on PD, frequent episodes of peritonitis, high glucose solution use, and high peritoneal transport status. Aim: To report the clinical features of patients on PD, who developed EPS. Material and methods: Review of medical records of 12 patients aged 43 ± 10 years (eight women) who developed EPS. Results: The mean time spent on PD was 98 months. The main clinical manifestations were abdominal pain in 82% and ultrafiltration failure in 63 %. In 92 %, there was a history of peritonitis and 75 % had high peritoneal transport at the time of diagnosis. The main findings in computed tomography were peritoneal calcification and thickening. There was a biopsy compatible with the diagnosis in 10 cases. Treatment consisted in withdrawal from PD, removal of PD catheter and the use of corticoids and tamoxifen. After withdrawal from PD 50% of patients became asymptomatic. The rest had intermittent abdominal pain and altered bowel movements. Two patients died (17 %). Conclusions: EPS is a serious complication of PD, which should be suspected in any patient with compatible clinical symptoms, long time on PD, multiple episodes of peritonitis and high peritoneal transport profile. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|